Skip to main
EHC

Encompass Health (EHC) Stock Forecast & Price Target

Encompass Health (EHC) Analyst Ratings

Based on 4 analyst ratings
Strong Buy
Strong Buy 75%
Buy 25%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Encompass Health is well-positioned for growth, with a successful Medicare strategy, consistent capacity expansion, and plans for future growth through new facilities and targeted market expansion. In addition, the company leverages regulations and utilizes predictive analytics and AI to improve operations and maintain a competitive advantage. With a strong financial position and a history of financial improvements, Encompass Health is poised for success in the ever-growing post-acute healthcare industry.

Bears say

Encompass Health is showing resilience with its strong financial performance despite challenges such as reimbursement rate reductions. However, the recent spin-off of its home health and hospice segment may impact its overall revenue growth. The company's plans for expansion and capital redeployment should be monitored closely, as slower growth and potential challenges from CMS may affect its bottom line.

Encompass Health (EHC) has been analyzed by 4 analysts, with a consensus rating of Strong Buy. 75% of analysts recommend a Strong Buy, 25% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Encompass Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Encompass Health (EHC) Forecast

Analysts have given Encompass Health (EHC) a Strong Buy based on their latest research and market trends.

According to 4 analysts, Encompass Health (EHC) has a Strong Buy consensus rating as of Sep 24, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $147.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $147.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Encompass Health (EHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.